Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
Crossref DOI link: https://doi.org/10.1007/s13238-017-0394-6
Published Online: 2017-03-13
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Guo, Yelei
Feng, Kaichao
Wang, Yao
Han, Weidong
License valid from 2017-03-13